4van Everdingen AA, Jacobs JW, Siewertsz Van Reesema DR,Bijlsma JW. Low-dose prednisone therapy for patients with early active rheumatoid arthritis: clinical efficacy, disease-modifying properties, and side effects: a randomized, double-blind, placebo-controlled clinical triah Ann Intern Med. 2002 J an 1; 136( 1 ): 1 - 12.
5Ward LE, Pollsy HF, PowerMH, Mason HL, Slocumb CH, Hench PS. Prednisone in rheumatoid arthritis:metabolic and clinical effects. Ann Rheum Dis. 1958 Jun;17(2):145-59.
6Harris ED J r, Emkey RD, Nichols JE, Newberg A. Low dose prednisone therapy in rheumatoid arthritis: a double blind study. J Rheumatol. 1983 0ct;10(5):713-21.
7Jacobs JW, van Everdingen AA, Verstappen SM, Bijlsma JW. Followup radiographic data on patients with rheumatoid arthritis who participated in a two-year trial of prednisone therapy or placebo. Arthritis Rheum. 2006 May;54(5): 1422-8.
8Kirwan JR. The effect of glueoeorticoids on joint destruction in rheumatoid arthritis. The Arthritis and Rheumatism Council Low-Dose Glueoeorticoid Study Group. N Engl J Med. 1995 Jul 20; 333(3):142-6.
9Paulus HE, Di Primeo D, Sanda M, Lynch JM, Schwartz BA, Sharp ..IT, Genant HK, Weissman BN. Progression of radiographic joint erosion during low dose corticosteroid treatment of rheumatoid arthritis. J Rheumatol. 2000 Jul;27(7): 1632-7.
10Capell HA, Madhok R, Hunter JA, Porter D, Morrison E, Larkin J, Thomson EA, Hampson R, Poon FW. Lack of radiological and clinical benefit over two ye, ars of low dose prednisoIone for rheumatoid arthritis: results of a randomised controlled trial. Ann Rheum Dis. 2004 Jul;63(7):797-803.
